title: Therapy concept in enuretic children.
abstract: More than 700 children aged between 5 and 15 years were treated at the University of Vienna Department of Urology during the last 10 years. The therapeutic approach was based on a complex diagnostic scheme to define the individual problem of each enuretic child. Generally speaking the enuresis problem turned out to be a symptom of delayed maturation of fine motor control [1] or sleep and hormone secretion rhythm during day and night hours. In a high percentage of enuretic children, no major physical problem or disease could be found, but the possibility of a physical problem, especially a neurourological problem, should not be ignored. Nonneurogenic discoordinated voiding in children can be treated by cognitive flow-triggered feedback training [2, 3] while overproduction of urine during sleep is reduced by antidiuretic hormone therapy with desmopressin (DDAVP; 1-deamino-8-D-arginine-vasopressin), a synthetic analogue of antidiuretic hormone.
authors.affiliation: Department of Urology, University of Vienna Medical School, Vienna, Austria. maria-angelika.etele@univie.ac.at
authors.forename: A
authors.initials: A
authors.lastname: Etele-Hainz
authors.forename: E
authors.initials: E
authors.lastname: Artens
authors.forename: M
authors.initials: M
authors.lastname: Marberger
mesh_terms: D000293:Adolescent; D001317:Austria; D002648:Child; D003894:Deamino Arginine Vasopressin / Q000008:administration & dosage / Q000627:therapeutic use*; D004775:Enuresis / Q000175:diagnosis / Q000523:psychology / Q000628:therapy*; D006801:Humans; D012076:Renal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D012189:Retrospective Studies; D013577:Syndrome; D014039:Toilet Training; D016896:Treatment Outcome
chemical_list: D012076:Renal Agents; D003894:Deamino Arginine Vasopressin